Calumet Inc. Fundamental Analysis (NASDAQ: CLMT)
Calumet Inc. (NASDAQ: CLMT) shows moderate financial fundamentals with a PE ratio of -15.92, profit margin of -3.73%, and ROE of 20.49%. The company generates $5.2B in annual revenue with weak year-over-year growth of -1.25%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze CLMT's fundamental strength across five key dimensions:
Efficiency Score
WeakCLMT struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCLMT trades at attractive valuation levels.
Growth Score
ModerateCLMT shows steady but slowing expansion.
Financial Health Score
ExcellentCLMT maintains a strong and stable balance sheet.
Profitability Score
ModerateCLMT maintains healthy but balanced margins.
Key Financial Metrics
Is CLMT Expensive or Cheap?
P/E Ratio
CLMT trades at -15.92 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CLMT's PEG of 0.04 indicates potential undervaluation.
Price to Book
The market values Calumet Inc. at -3.62 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -30.80 times EBITDA. This is generally considered low.
How Well Does CLMT Make Money?
Net Profit Margin
For every $100 in sales, Calumet Inc. keeps $-3.73 as profit after all expenses.
Operating Margin
Core operations generate 3.45 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $20.49 in profit for every $100 of shareholder equity.
ROA
Calumet Inc. generates $-6.47 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Calumet Inc. generates limited operating cash flow of $340.61M, signaling weaker underlying cash strength.
Free Cash Flow
Calumet Inc. produces free cash flow of $264.72M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.01 in free cash annually.
FCF Yield
CLMT converts 8.38% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-15.92
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.04
vs 25 benchmark
P/B Ratio
Price to book value ratio
-3.62
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-2.49
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.20
vs 25 benchmark
ROA
Return on assets percentage
-0.06
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How CLMT Stacks Against Its Sector Peers
| Metric | CLMT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -15.92 | 25.20 | Better (Cheaper) |
| ROE | 20.49% | 1280.00% | Weak |
| Net Margin | -3.73% | 984.00% | Weak |
| Debt/Equity | -2.49 | 0.64 | Strong (Low Leverage) |
| Current Ratio | 1.06 | 2.91 | Neutral |
| ROA | -6.47% | -28.00% (disorted) | Weak |
CLMT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Calumet Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
64.75%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
79.51%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
56.63%
Industry Style: Cyclical, Commodity, Value
High Growth